ROCKVILLE, Md.--(BUSINESS WIRE)-- Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the company’s senior management team will provide a corporate overview presentation, which may include a discussion of recent business developments and financial guidance for full year 2011, at the following investor conferences during November 2011.
- Lazard Capital Markets’ 8thAnnual Healthcare Conference
New York, NY
November 16, 2011
10:00 AM Eastern
- Piper Jaffray’s 23rdAnnual Health Care Conference
New York, NY
November 29, 2011
10:10 AM Eastern
- J. P. Morgan’s 10thAnnual SMid Cap Conference
New York, NY
November 30, 2011
8:45 AM Eastern
Webcasts of these presentations will be available both live and by replay, accessible from the Emergent website www.emergentbiosolutions.com under “Investors”.
About Emergent BioSolutions Inc.
Emergent BioSolutions protects and enhances life by developing and manufacturing vaccines and therapeutics that are supplied to healthcare providers and purchasers for use in preventing and treating disease. Emergent's marketed and investigational products target infectious diseases, oncology and autoimmune disorders. Additional information about the company may be found at www.emergentbiosolutions.com.
CONTACT:
Emergent BioSolutions Inc.
Investors Contact:
Robert G. Burrows
Vice President, Investor Relations
301-795-1877
[email protected]
or
Media Contact:
Tracey Schmitt
Vice President, Corporate Communications
301-795-1800
[email protected]
KEYWORDS: United States North America Maryland
INDUSTRY KEYWORDS: Health Biotechnology Pharmaceutical Professional Services Finance
MEDIA:
| Logo |